Charles Schwab Investment Management Inc Biomea Fusion, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 178,935 shares of BMEA stock, worth $805,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,935
Previous 176,797
1.21%
Holding current value
$805,207
Previous $2.57 Million
4.21%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BMEA
# of Institutions
121Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$20.2 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$16.1 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$12.2 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.49 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.88 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $132M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...